These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7258018)

  • 61. [Immune response and serum IgG level in the acute stage of experimental Erysipelothrix insidiosa infection in rats].
    Toshkov A; Noeva K
    Acta Microbiol Virol Immunol (Sofiia); 1976; 3():16-19. PubMed ID: 1007947
    [No Abstract]   [Full Text] [Related]  

  • 62. Experimental erysipelothrix arthritis. II. Observations on rabbits following systemic administration of live E. rhusiopathiae or an intra-articular injection of non-living substances including inactivated organisms.
    Ajmal M
    Res Vet Sci; 1971 Sep; 12(5):412-9. PubMed ID: 5097757
    [No Abstract]   [Full Text] [Related]  

  • 63. [Immunity against Erysipelothrix rhusiopathiae infection by means of active immunization using homologous neuraminidase (author's transl)].
    Muller HE; Krasemann C
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):237-41. PubMed ID: 134541
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Attenuated acriflavin-fast Erysipelothrix insidiosa. Relationship between its capability to cause arthritis in mice and immunogenicity in swine].
    Seto K; Nishimura Y; Fujiki M; Azechi H; Suzuki K
    Nihon Juigaku Zasshi; 1971 Aug; 33(4):161-71. PubMed ID: 5106229
    [No Abstract]   [Full Text] [Related]  

  • 65. Synovitis induced by killed Erysipelothrix rhusiopathiae. Extended reaction in passively immunized lambs.
    Piercy DW
    J Comp Pathol; 1971 Oct; 81(4):557-62. PubMed ID: 5002723
    [No Abstract]   [Full Text] [Related]  

  • 66. Isolation of a high-molecular mass glycoprotein from culture supernatant of an arthritogenic strain of the bacteria Erysipelothrix rhusiopathiae reacting with "inductive" monoclonal antibodies derived from rats with erysipelas polyarthritis.
    Meier B; Brunotte CM; Franz B; Warlich B; Petermann M; Ziesenis A; Schuberth HJ; Habermehl GG; Petzoldt K; Leibold W
    Biol Chem Hoppe Seyler; 1992 Aug; 373(8):715-21. PubMed ID: 1384550
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunological characterization of protective antigens prepared by alkaline treatment of whole cells and from the culture filtrate of Erysipelothrix rhusiopathiae.
    Kobayashi S; Sato H; Hirose K; Saito H
    Vet Microbiol; 1992 Jan; 30(1):73-85. PubMed ID: 1531564
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Properties of the lyophilized anti-swine-erysipelas vaccine (VR2)].
    Bodurova Ts
    Vet Med Nauki; 1973; 10(9):65-9. PubMed ID: 4792313
    [No Abstract]   [Full Text] [Related]  

  • 69. [Protective antigens of the swine erysipelas bacterium (Erysipelothrix rhusiopathiae. 2. Further characterization of the protective antigen].
    Rothe F
    Arch Exp Veterinarmed; 1982; 36(2):255-67. PubMed ID: 6808966
    [No Abstract]   [Full Text] [Related]  

  • 70. [Comparative effectiveness of vaccines against erysipelas].
    Koniaev MT; Shcherbinin VK
    Veterinariia; 1980 Mar; (3):33-4. PubMed ID: 7395054
    [No Abstract]   [Full Text] [Related]  

  • 71. Some biological and physical chemical properties of Erysipelothrix rhusiopathiae.
    White TG; Mirikitani FK
    Cornell Vet; 1976 Apr; 66(2):152-63. PubMed ID: 1261268
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cutaneous Erysipelothrix rhusiopathiae (erysipeloid) infection in an immunocompromised child.
    Boyd AS; Ritchie C; Fenton JS
    Pediatr Dermatol; 2014; 31(2):232-5. PubMed ID: 22957967
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Studies on the suitability of basic aluminum chloride as adjuvant in the production of erysipelas adsorbate vaccine].
    Meese M; Gürtler D
    Arch Exp Veterinarmed; 1966 Mar; 20(1):141-50. PubMed ID: 5983260
    [No Abstract]   [Full Text] [Related]  

  • 74. Acute and chronic Erysipelothrix rhusiopathiae infection in white mice.
    Geissinger HD
    J Comp Pathol; 1968 Jan; 78(1):79-88. PubMed ID: 4870832
    [No Abstract]   [Full Text] [Related]  

  • 75. iTRAQ-based quantitative proteomic analysis reveals potential virulence factors of Erysipelothrix rhusiopathiae.
    Wang Y; Li J; Zhang A; Zhu W; Zhang Q; Xu Z; Yan S; Sun X; Chen H; Jin M
    J Proteomics; 2017 May; 160():28-37. PubMed ID: 28284755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of cyclophosphamide and carrageenan on resistance of mice to Erysipelothrix rhusiopathiae.
    Sawada T; Tamura Y; Takahashi T
    Vet Microbiol; 1987 Dec; 15(4):341-6. PubMed ID: 3439021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterisation of Erysipelothrix rhusiopathiae isolates from pigs associated with vaccine breakdowns.
    Eamens GJ; Forbes WA; Djordjevic SP
    Vet Microbiol; 2006 Jul; 115(4):329-38. PubMed ID: 16621346
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Aerogenic immunization against swine erysipelas with Spirovak erysipelas vaccine "Dessau"].
    Urbaneck D; Stöhr P; Michael-Meese M
    Arch Exp Veterinarmed; 1980; 34(1):51-4. PubMed ID: 7416893
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Virulence and neuraminidase activity of Erysipelothrix rhusiopathiae].
    Nikolov P; Abrashev I; Ilieva K; Avramova T
    Acta Microbiol Bulg; 1978; 2():62-5. PubMed ID: 751479
    [No Abstract]   [Full Text] [Related]  

  • 80. Invasive Erysipelothrix rhusiopathiae infection in northeast Thailand.
    Mahavanakul W; Limmathurotsakul D; Teerawattanasuk N; Peacock SJ
    Southeast Asian J Trop Med Public Health; 2007 May; 38(3):478-81. PubMed ID: 17877222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.